Bắt đầu
ABBVIE INCABBVIE INCABBVIE INC

ABBVIE INC

Không có giao dịch
Xem siêu biểu đồ
Tổng quan Tài chính Ý tưởng Thảo luận Kỹ thuật Dự đoán
Trái phiếu

Trái phiếu ABBV

Sau đây là danh sách trái phiếu doanh nghiệp ABBVIE INC. Các nhà đầu tư thường lựa chọn trái phiếu của công ty vì tính ổn định cao hơn trong thời điểm thị trường biến động. Nghiên cứu giá cả, lợi suất và các số liệu thống kê khác và tìm khoản đầu tư đáng tin cậy.
Mã
Lợi suất đáo hạn %
Giá %
Phiếu giảm giá %
Ngày đáo hạn
Giá trị dư nợ
Giá trị khuôn mặt
Giá trị mệnh giá tối thiểu
Bên phát hành
AACT3910526Actavis, Inc. 4.625% 01-OCT-2042
6.72%76.50%4.63%2042-10-0167.493 M USD1,000.00 USD2,000.00 USDActavis, Inc.
AACT4176286Allergan Funding SCS 4.85% 15-JUN-2044
6.63%78.76%4.85%2044-06-1565.232 M USD1,000.00 USD2,000.00 USDAllergan Funding SCS
AACT4218883Allergan Funding SCS 4.75% 15-MAR-2045
6.26%81.10%4.75%2045-03-1553.51 M USD1,000.00 USD2,000.00 USDAllergan Funding SCS
AACT4218882Allergan Funding SCS 4.55% 15-MAR-2035
5.80%89.99%4.55%2035-03-15107.646 M USD1,000.00 USD2,000.00 USDAllergan Funding SCS
ABBV4911706AbbVie Inc. 3.2% 21-NOV-2029
5.21%90.84%3.20%2029-11-2162.515 M USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5759196AbbVie Inc. 5.5% 15-MAR-2064
5.09%108.07%5.50%2064-03-151.5 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5759195AbbVie Inc. 5.4% 15-MAR-2054
4.96%107.42%5.40%2054-03-153 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
US287YAW9ABBVIE 16/46
4.93%93.18%4.45%2046-05-142 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5068388AbbVie Inc. 4.625% 01-OCT-2042
4.90%96.56%4.63%2042-10-01389.217 M USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5068387AbbVie Inc. 4.25% 21-NOV-2049
4.89%90.05%4.25%2049-11-215.745 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5068389AbbVie Inc. 4.85% 15-JUN-2044
4.88%99.63%4.85%2044-06-151.008 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5068390AbbVie Inc. 4.75% 15-MAR-2045
4.87%98.34%4.75%2045-03-15827.091 M USD1,000.00 USD2,000.00 USDAbbVie, Inc.
4ABBABBVIE 15/45
4.87%97.69%4.70%2045-05-142.7 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5759204AbbVie Inc. 5.35% 15-MAR-2044
4.86%106.53%5.35%2044-03-15750 M USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV4693583AbbVie Inc. 4.875% 14-NOV-2048
4.84%100.53%4.88%2048-11-141.75 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV4036937AbbVie Inc. 4.4% 06-NOV-2042
4.80%94.91%4.40%2042-11-062.599 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV4911704AbbVie Inc. 2.95% 21-NOV-2026
4.64%96.53%2.95%2026-11-219.245 M USD1,000.00 USD2,000.00 USDAbbVie, Inc.
AA5QDALLERGAN FNDG 15/25
4.64%99.18%3.80%2025-03-15130.225 M USD1,000.00 USD2,000.00 USDAllergan Funding SCS
ABBV5068386AbbVie Inc. 4.05% 21-NOV-2039
4.63%93.48%4.05%2039-11-214 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
US287YAV1ABBVIE 16/36
4.57%97.48%4.30%2036-05-141 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5082874AbbVie Inc. 4.55% 15-MAR-2035
4.48%100.64%4.55%2035-03-151.681 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
US287YAR0ABBVIE 15/35
4.46%100.34%4.50%2035-05-142.5 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5759203AbbVie Inc. 5.05% 15-MAR-2034
4.45%104.70%5.05%2034-03-153 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
4ABCABBVIE 15/25
4.23%99.39%3.60%2025-05-143.75 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5083839AbbVie Inc. 3.8% 15-MAR-2025
4.21%99.60%3.80%2025-03-152.889 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5759202AbbVie Inc. 4.95% 15-MAR-2031
4.18%104.37%4.95%2031-03-152 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5084327AbbVie Inc. 3.2% 21-NOV-2029
4.06%95.99%3.20%2029-11-215.437 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
US287YAY5ABBVIE 16/26
3.98%98.77%3.20%2026-05-142 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5758814AbbVie Inc. 4.8% 15-MAR-2029
3.98%103.38%4.80%2029-03-152.5 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5084339AbbVie Inc. 2.95% 21-NOV-2026
3.86%98.12%2.95%2026-11-213.991 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV4693581AbbVie Inc. 4.25% 14-NOV-2028
3.85%101.52%4.25%2028-11-141.75 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5758813AbbVie Inc. 4.8% 15-MAR-2027
3.80%102.36%4.80%2027-03-152.25 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
XXS162262122ALLERGAN FNDG 17/29
3.79%92.84%2.13%2029-06-0136.462 M EUR1,000.00 EUR100,000.00 EURAllergan Funding SCS
XS190919331ALLERGAN FNDG 18/28
3.66%96.02%2.63%2028-11-1572.107 M EUR1,000.00 EUR100,000.00 EURAllergan Funding SCS
ABBV4911718AbbVie Inc. 4.25% 21-NOV-2049
3.08%121.31%4.25%2049-11-214.95 M USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5066461AbbVie Inc. 2.6% 21-NOV-2024
3.05%99.56%2.60%2024-11-213.739 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV4998675AbbVie Inc. 4.75% 15-MAR-2045
3.04%126.76%4.75%2045-03-155 K USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5006799AbbVie Inc. 4.85% 15-JUN-2044
2.97%128.71%4.85%2044-06-15100 K USD1,000.00 USD2,000.00 USDAbbVie, Inc.
4ABGABBVIE 19/31
2.89%89.35%1.25%2031-11-18650 M EUR1,000.00 EUR100,000.00 EURAbbVie, Inc.
XS212591483ABBVIE 20/28
2.75%99.50%2.63%2028-11-15427.793 M EUR1,000.00 EUR100,000.00 EURAbbVie, Inc.
XS212591491ABBVIE 20/29
2.72%97.39%2.13%2029-06-01506.088 M EUR1,000.00 EUR100,000.00 EURAbbVie, Inc.
XS152090781ABBVIE 16/28
2.66%97.88%2.13%2028-11-17750 M EUR1,000.00 EUR100,000.00 EURAbbVie, Inc.
4ABEABBVIE 19/27
2.64%94.28%0.75%2027-11-18750 M EUR1,000.00 EUR100,000.00 EURAbbVie, Inc.
ABBV5006798AbbVie Inc. 4.55% 15-MAR-2035
2.04%123.74%4.55%2035-03-151 K USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV4997740AbbVie Inc. 3.8% 15-MAR-2025
1.63%102.15%3.80%2025-03-151.268 M USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV4911714AbbVie Inc. 2.6% 21-NOV-2024
−3.63%106.34%2.60%2024-11-2110.86 M USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5067241AbbVie Inc. 3.8% 15-MAR-2025
——3.80%2025-03-15—1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV3926786AbbVie Inc. 4.4% 06-NOV-2042
——4.40%2042-11-061.1 M USD1,000.00 USD2,000.00 USDAbbVie, Inc.